HEALTHCARE-ACQUIRED INFECTIONS AND ANTIMICROBIAL RESISTANCE

Similar documents
Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them?

Multi-Drug Resistant Organisms (MDRO)

Horizontal vs Vertical Infection Control Strategies

Surveillance for Antimicrobial Resistance and Preparation of an Enhanced Antibiogram at the Local Level. janet hindler

Does Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs?

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011

Evaluating the Role of MRSA Nasal Swabs

The importance of infection control in the era of multi drug resistance

DR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA

MDR Acinetobacter baumannii. Has the post antibiotic era arrived? Dr. Michael A. Borg Infection Control Dept Mater Dei Hospital Malta

SURVIVABILITY OF HIGH RISK, MULTIRESISTANT BACTERIA ON COTTON TREATED WITH COMMERCIALLY AVAILABLE ANTIMICROBIAL AGENTS

Summary of the latest data on antibiotic resistance in the European Union

Antibiotic Resistance in the Post-Acute and Long-Term Care Settings: Strategies for Stewardship

03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline

New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs

1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection

High-Risk MDR clones news in treatment

Source: Portland State University Population Research Center (

Nosocomial Antibiotic Resistant Organisms

APIC CHAPTER PRESENTATION 7/2014

Rise of Resistance: From MRSA to CRE

Nosocomial Infections: What Are the Unmet Needs

Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC

A snapshot of polymyxin use around the world South America

Birgit Ross Hospital Hygiene University Hospital Essen Essen, Germany. Should we screen for multiresistant gramnegative Bacteria?

Active Bacterial Core Surveillance Site and Epidemiologic Classification, United States, 2005a. Copyright restrictions may apply.

Other Enterobacteriaceae

Appropriate antimicrobial therapy in HAP: What does this mean?

Understanding the Hospital Antibiogram

Preventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal

UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM

Multi-drug resistant microorganisms

GENERAL NOTES: 2016 site of infection type of organism location of the patient

Nosocomial Antibiotic Resistant Organisms MRSA & VRE

Your Guide to Managing. Multi Drug-resistant Organisms (MDROs)

Why should we care about multi-resistant bacteria? Clinical impact and

Surveillance of Multi-Drug Resistant Organisms

Carbapenemase-Producing Enterobacteriaceae (CPE)

MDRO s, Stewardship and Beyond. Linda R. Greene RN, MPS, CIC

2017 Introduction to Infectious Diseases Clinical Seminar Saturday 30th September - Sunday 1st October 2017 Hotel Grand Chancellor Hobart, Tasmania

Surveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at Chiang Mai University Hospital,

Fighting MDR Pathogens in the ICU

Carbapenemase-producing Enterobacteriaceae (CRE) T H E L A T E S T I N T H E G R O W I N G L I S T O F S U P E R B U G S

OPTIMIZATION OF PK/PD OF ANTIBIOTICS FOR RESISTANT GRAM-NEGATIVE ORGANISMS

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections Activity C: ELC Prevention Collaboratives

Antimicrobial Susceptibility Patterns

Screening programmes for Hospital Acquired Infections

Multi-drug resistant Acinetobacter (MDRA) Surveillance and Control. Alison Holmes

Is biocide resistance already a clinical problem?

Hand Hygiene and MDRO (Multidrug-resistant Organisms) - Science and Myth PROF MARGARET IP DEPT OF MICROBIOLOGY

2017 Introduction to Infectious Diseases Clinical Seminar Saturday 30th September - Sunday 1st October 2017 Hotel Grand Chancellor Hobart, Tasmania

Lindsay E. Nicolle University of Manitoba Winnipeg, CANADA

Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune

INCIDENCE OF BACTERIAL COLONISATION IN HOSPITALISED PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS

Microbiology. Multi-Drug-Resistant bacteria / MDR: laboratory diagnostics and prevention. Antimicrobial resistance / MDR:

Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050? Prof. Stephan Harbarth Infection Control Program Geneva, Switzerland

COMMISSION OF THE EUROPEAN COMMUNITIES

Antimicrobial Resistance and Molecular Epidemiology of Staphylococcus aureus in Ghana

Two (II) Upon signature

Today s Agenda: 9/30/14

Hospital Acquired Infections in the Era of Antimicrobial Resistance

Infection control in Indonesian hospitals

Antimicrobial Cycling. Donald E Low University of Toronto

Healthcare-associated Infections and Antimicrobial Use Prevalence Survey

The International Collaborative Conference in Clinical Microbiology & Infectious Diseases

ETX2514SUL (sulbactam/etx2514) for the treatment of Acinetobacter baumannii infections

Infection Control of Emerging Diseases

Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE

48 th Annual Meeting. IDWeek and ICAAC: The Cliffs Notes Version. Skin and Soft Tissue Infections. Skin and Soft Tissue Infections.

DRUG-RESISTANT ACINETOBACTER BAUMANNII A GROWING SUPERBUG POPULATION. Cara Wilder Ph.D. Technical Writer March 13 th 2014

Update on Resistance and Epidemiology of Nosocomial Respiratory Pathogens in Asia. Po-Ren Hsueh. National Taiwan University Hospital

Hand washing/hand hygiene reduces the number of microorganisms on the hands and is the most important practice to prevent the spread of infection.

Mono- versus Bitherapy for Management of HAP/VAP in the ICU

INFECTION PREVENTION SILVER ANTI-MICROBIAL TEXTILES

Burden of disease of antibiotic resistance The example of MRSA. Eva Melander Clinical Microbiology, Lund University Hospital

TACKLING THE MRSA EPIDEMIC

Antibiotic resistance: the rise of the superbugs

Surveillance of AMR in PHE: a multidisciplinary,

Approval Signature: Original signed by Dr. Michel Tetreault Date of Approval: July Review Date: July 2017

MDRO in LTCF: Forming Networks to Control the Problem

SECOND REPORT FROM THE COMMISSION TO THE COUNCIL

Antimicrobial resistance (EARS-Net)

Infection Linelist. Infections Occurred Between 10/1/ :00:00 AM To 11/1/ :00:00 AM 2RCW2. Gastroenteritis (Adult) Urinary Tract

Infection Control & Prevention

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre

Proceedings of the 19th American Academy of Veterinary Pharmacology and Therapeutics Biennial Symposium

Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16

Antibiotic resistance in West Africa

Hospital ID: 831. Bourguiba Hospital. Tertiary hospital

PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE

Healthcare-associated Infections Annual Report December 2018

Responders as percent of overall members in each category: Practice: Adult 490 (49% of 1009 members) 57 (54% of 106 members)

Combating Antibiotic Resistance: New Drugs 4 Bad Bugs (ND4BB) Subtopic 1C. Seamus O Brien and Hasan Jafri Astra Zeneca and MedImmune

Impact of a Standardized Protocol to Address Outbreak of Methicillin-resistant

Infection Prevention Highlights for the Medical Staff. Pamela Rohrbach MSN, RN, CIC Director of Infection Prevention

List of Seminars and invited special lectures delivered on behalf of GMERF

Overview of Infection Control and Prevention

Multidrug Resistant Organisms (MDROs) and Clostridium difficile (C. diff)

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Enterococcal Species

Transcription:

Universidade de São Paulo Departamento de Moléstias Infecciosas e Parasitárias HEALTHCARE-ACQUIRED INFECTIONS AND ANTIMICROBIAL RESISTANCE Anna S. Levin

4 main lines! Epidemiology of HAS and resistance! Interface between hospital practices/problems and laboratory! Antimicrobial drug use! Miscellaneous/Incidental

Setting 1 Hospital da Clínicas! Tertiary care! University of São Paulo! 2,200 bed! Different institutes! Central! Heart! Children s! Orthopedics! Cancer! Radiology! Psychiatry/ Neurosurgery! 2 long term care! Physical rehabilitation

Hospital das Clínicas! 250 ICU beds! Neonatal and pediatric ICUs! Transplantation! Kidney/kidney-pancreas! Heart! Lung! Bone marrow

Studies! Application of mathematical model as a strategy to reduce colonization and infection by carbapenemresistant K. pneumoniae in an ICU.

Mathematical model Admissã o Admissã o Alta Alta

Modelo de Ross-Macdonald R 0 R 0 >1 R 0 <1

Mathematical model

22% 45%?? 10%

Impact of different hand hygiene compliance rates if 80% compliance with contact precautions ρ: adesão à higiene das mãos

What happened...

Studies! Evaluation of factors associated with MRSA carriage in newborns - cohort study.

MRSA in neonatal unit 16 Figure 2: Distribution of molecular patterns of methicillin-resistant Staphylococcus aureus in colonized newborns between February 2009 through January 2010 at Hospital das Clínicas of University of São Paulo, Brazil 14 12 Molecular PFGE patterns 10 8 6 4 2 0 0 50 100 150 200 250 300 350 400 time (days)

Studies! Impact of chlorhexedine bathing on HAI caused by MDR in HSCT patients! Chlorhexedine breakpoints, PCR for chlorhexedine resistance genes! Study of human difficulties and adherence to infectionprevention measures (Collaboration with Institute of Psychology and Nursing School, USP)! Impact of bacteremic infections caused by Acinetobacter baumannii on mortality in ICU patients in comparison with other bacteria (K. pneumoniae, P.aeruginosa, S. aureus).- a retrospective cohort study (two hospitals)

Setting 2 São Paulo State Health Department São Paulo State Health Department! 40,000 inhabitants! 838 hospitals: 383 have ICUs.! Since 2004 reporting of HA-infection rates! Surgical site infections in clean surgery! Infection rates in ICU (includes neonatal)! Blood culture results! Frequency of specific patterns of resistance

http://www.cve.saude.sp.gov.br/htm/ih/pdf/dados_ih_2012.pdf State of São Paulo Device-associated infection rates in ICU VA-Pneumonia Urinary tract infections Bloodstream infections

http://www.cve.saude.sp.gov.br/htm/ih/pdf/dados_ih_2012.pdf State of São Paulo - 2012 Bloodcultures

http://www.cve.saude.sp.gov.br/htm/ih/pdf/dados_ih_2012.pdf State of São Paulo - 2012 Patterns of resistance

Epidemiology of HAS and resistance Collaboration with the São Paulo State Health Department! Statewide evaluation of the prevalence of BSI by resistant bacteria and potential association with sales of antimicrobials and socio-demographic factors- Databases: drug sales 2008-2012, compulsory notification of resistant BSI to State Government and 2010 census spacial analysis (Public Health School, USP)! Evaluation of the effect of climate on nosocomial BSI in ICU of the State- comparison with seasonal behaviour of other diseases notified to the Government. (Institute of Oceanography, USP)

Epidemiology of HAS and resistance Collaboration with the São Paulo State Health Department! Evaluation of strategy to reduce nosocomial BSI in ICU of State of São Paulo (SSP)

Setting 3 Medical Investigation Laboratory 54 (LIM-54)! Medical Investigation Laboratory 54 (LIM-54)! Located in Institute for Tropical Medicine-USP! Capabilities:! Basic microbiology (bacterial and fungal)! Mechanisms of antimicrobial resistance! Typing! Sequencing

Perdigão et al. Antimicrob. Agents Chemother. 2014, 58(3):1763-7 Studies! Study of susceptibility of clinical isolates of MDR gramnegative bacteria to fosfomycin

Studies! Development of PCR method of detection of Fusarium spp. in water.! In vitro activity of Silver nanoparticles (NanoAg) against multidrug resistant bacteria and yeast:! breakpoints; time-kill and activity on biofilm

Studies! Polymyxins heteroresistance in A. baumannii isolates.! Mechanisms of resistance in carbapenem-resistant E. aerogenes and E. cloacae.! S. maltophila: genome of TMP-SMX and levofloxacin isolates (comparison of susceptible and resistant isolates)! Whole genome sequencing! VRE in HSCT patients! Virulence, resistance and clonality

Microbiome! Study of microbiome in women with recurrent cystitis.! Evaluation of microorganisms that cause postoperative meningitis using sequencing.

Microbiome! Study of microbiome in women with recurrent cystitis.! Evaluation of microorganisms that cause postoperative meningitis using sequencing.

4 main lines! Epidemiology of HAS and resistance! Interface between hospital practices/problems and laboratory! Antimicrobial drug use! Miscellaneous/Incidental

Antimicrobial drug use Collaboration with School of Pharmaceutical Sciences, USP! Effect of the use of prescribing antimicrobial with adjustment based of serum levels and PK/PD parameters, on outcome of infections in burn patients (time series)! Evaluation of drug pharmacockinetics and pharmacodynamics of antimicrobial drugs in sustained low-efficiency dialysis (SLED) in critically ill patients.

Antimicrobial drug use! Case-series of patients with severe MDR infections treated with IV fosfomycin! Retrospective evaluation of outcomes of patients with severe infections caused by KPC-carrying organisms and effect of different antimicrobial treatments (two hospitals)! National survey of the patterns of antimicrobial use in terminally ill patients Brazil, Portugal and Argentina.! Randomized, double-blind controlled study of cetriaxone ± azythromycin in comunity-acquired pneumonia in HIVinfected patients (Collaboration with Emilio Ribas Infectious Disease Hospital).

Universidade de São Paulo Departamento de Moléstias Infecciosas e Parasitárias Infection Control Department and LIM 54 (Medical Investigation Lab- 54)! Anna Sara Levin! Silvia F. Costa! E-mail: gcih.adm@hc.fm.usp.br! Phone/fax: 55-11- 2661 7066